Emergent BioSolutions Inc. — Director's Dealing 2026

Mar 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2026-03-01

Reporting Person: Glessner Coleen (EVP, Quality & Ethics, and CPL)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-03-01	Common Stock	F	313	$8.15	Disposed	112307	Direct

Footnotes

F1: Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.